DCF ADVISERS, LLC – Regeneron Pharmaceuticals, Inc. Transaction History
DCF ADVISERS, LLC portfolio value:
$0
portfolio value
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -12.99% | -1.65K shares | 105K | $688.87 | 11.05K |
| Q3 2022 | call | Decrease | -100.00% | -600 shares | -355K | $688.87 | 0 |
| Q2 2022 | share | Decrease | -13.61% | -2K shares | -2.76M | $591.13 | 12.7K |
| Q2 2022 | call | Increase | 0.00% | 600 shares | 355K | $591.13 | 600 |
| Q2 2022 | put | Decrease | -100.00% | -3K shares | -2.09M | $591.13 | 0 |
| Q1 2022 | call | Decrease | -100.00% | -200 shares | -126K | $698.42 | 0 |
| Q1 2022 | share | Decrease | -14.53% | -2.5K shares | -595K | $698.42 | 14.7K |
| Q1 2022 | put | Increase | 0.00% | 3K shares | 2.09M | $698.42 | 3K |
| Q4 2021 | call | Increase | 0.00% | 200 shares | 126K | $642.51 | 200 |
| Q4 2021 | share | Increase | +7.50% | 1.2K shares | 1.17M | $642.51 | 17.2K |
| Q3 2021 | share | Increase | +3.23% | 500 shares | 1.02M | $605.18 | 16K |
| Q2 2021 | share | Increase | +14.81% | 2K shares | 2.27M | $558.54 | 15.5K |
| Q1 2021 | share | Increase | +8.87% | 1.1K shares | 396K | $473.14 | 13.5K |
| Q4 2020 | share | 0.00% | 0 shares | -950K | $483.11 | 12.4K | |
| Q3 2020 | share | 0.00% | 0 shares | -792K | $559.78 | 12.4K | |
| Q2 2020 | share | Increase | +2.06% | 250 shares | 1.8M | $623.65 | 12.4K |
| Q1 2020 | share | Decrease | -9.33% | -1.25K shares | 902K | $488.29 | 12.15K |
| Q4 2019 | share | Increase | 0.00% | 13.4K shares | 5.03M | $375.48 | 13.4K |